January 18, 2020.
Poster Presentation
Rueb K, Stachura DL.
CRISPR/Cas9 technology indicates that ccl44 is essential for normal embryonic hematopoiesis.
32nd Annual CSU Biotechnology Symposium, Santa Clara, CA.
Glenn Nagel Undergraduate Research Award finalist (one of the top eight undergraduate posters presented at this statewide meeting from across 23 CSU campuses)
​
July 16, 2019.
Poster Presentation
Laurie P, Rueb K, Griffin K, Stachura DL.
ccl44: a chemokine critical for normal hematopoiesis. Zebrafish Disease Models 12 Meeting, Boston, MA.
Publications
April 29, 2021.
Journal of Visualized Experiments
Rueb K, Stachura DL.
Utilizing flow cytometry to detect and quantitate altered blood formation in the developing zebrafish.
doi: 10.3791/61035
​
August 11, 2020.
PLOS ONE
Lewis TR, Smith J, Griffin K, Aguiar S, Rueb K, Holmberg-Douglas N, Sampson EM, Tomasetti S, Rodriguez S, Stachura DL, Arpin C.
NHD2-15, a Novel Antagonist of Growth Factor Receptor-Bound Protein-2 (GRB2), Inhibits Leukemic Proliferation. doi:10.1371/journal.pone.0236839